SEC Comment Letter 0000000000-23-005588 to ARM HOLDINGS PLC /UK (ARM) (CIK 0001973239) (ARM)
ARM HOLDINGS PLC /UK (ARM) (CIK 0001973239)
Date: May 25, 2023 · CIK: 0001973239 · Accession: 0000000000-23-005588
AI Filing Summary & Sentiment
Show Raw Text
United States securities and exchange commission logo
May 25, 2023
Spencer Collins
Chief Legal Officer
Arm Holdings Limited
110 Fulbourn Road
Cambridge CB1 9NJ
United Kingdom
Re:Arm Holdings Limited
Draft Registration Statement on Form F-1
Submitted on April 28, 2023
CIK No. 0001973239
Dear Spencer Collins:
We have reviewed your draft registration statement and have the following comments. In
some of our comments, we may ask you to provide us with information so we may better
understand your disclosure.
Please respond to this letter by providing the requested information and either submitting
an amended draft registration statement or publicly filing your registration statement on
EDGAR. If you do not believe our comments apply to your facts and circumstances or do not
believe an amendment is appropriate, please tell us why in your response.
After reviewing the information you provide in response to these comments and your
amended draft registration statement or filed registration statement, we may have additional
comments.
Draft Registration Statement on Form F-1
Risk Factors
Actual or perceived security vulnerabilities in our information technology systems, including
cyberattacks, security breaches..., page 41
1.We note that you may be subject to cyberattacks. Please update your risks characterized
as potential if you have experienced a cyberattack.
SoftBank's interests may conflict with our own interests and those of holders of our ADSs., page
52
2.We note your disclosure that SoftBank is not restricted from competing with you or
FirstName LastNameSpencer Collins
Comapany NameArm Holdings Limited
May 25, 2023 Page 2
FirstName LastNameSpencer Collins
Arm Holdings Limited
May 25, 2023
Page 2
otherwise taking for itself or its other affiliates certain corporate opportunities that may be
attractive to you. Please revise your cross-reference here to clarify which related party
transaction this applies to.
Risks Relating to this Offering and Ownership of Our Securities, page 59
3.Please revise to add a risk factor regarding the deposit agreement’s limitations on
obligations and liabilities that are discussed on pages 175 and 176.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Key Factors and Trends Affecting Our Operating Results, page 78
4.We note your disclosures about your two non-recourse facilities with SoftBank and
SoftBank Vision Fund, such as on page 141. Please revise to discuss any known trends,
uncertainties, and commitments, such as the recurrence of these facilities, which are
reasonably likely to have a material effect on your results of operations or financial
condition. Further, please revise to add a risk factor discussing such known trends,
uncertainties, and commitments about these non-recourse facilities.
Reconciliation of Non-GAAP Financial Measures, page 85
5.The reconciliations here include an adjustment for equity-settled share-based
compensation expense of $30 million for the fiscal year ended March 31, 2022. Please
revise footnote (1) to the tables to clearly explain why equity-settled share-based
compensation expense was more than the total share-based compensation expense of $26
for the fiscal year ended March 31, 2022.
Research and development, page 90
6.We note your disclosure that your government research grant income decreased in the
fiscal year ended March 31, 2022 as compared to the comparable period in 2021 due to a
non-recurring government research grant income recognized in the prior fiscal year.
Please tell us if this research grant refers to the Innovate U.K. grant in fiscal years ended
March 31, 2022 and 2021, as disclosed on F-25. If so, please revise to clarify how this
was a non-recurring government research income in 2021, but not in 2022.
Liquidity and Capital Resources, page 92
7.We note your disclosure on page 45 that you have experienced material weaknesses in
your internal control over financial reporting. Please revise to discuss any material cash
requirements from remediation efforts.
Business
Our Market Opportunity, page 107
8.Please provide the basis or source for your March 31, 2023 total addressable market and
compound annual growth rate.
FirstName LastNameSpencer Collins
Comapany NameArm Holdings Limited
May 25, 2023 Page 3
FirstName LastNameSpencer Collins
Arm Holdings Limited
May 25, 2023
Page 3
Management and Executive Remuneration
Remuneration of Executive Officers and Directors, page 130
9.Please file your executive officer employment agreements, director remuneration policy
and Arm Annual Bonus Plan. Please refer to Item 601(b)(10)(iii) of Regulation S-K or
tell us why such exhibits are not required.
Financial Statements
Notes to Consolidated Financial Statements
1. Description of Business and Summary of Significant Accounting Policies
Revenue Recognition, page F-18
10.Please refer to the License and Other Revenues discussion on page 86 and revise this note
to address the following:
•Disclose the timing of your revenue recognition for licensing products still under
development, and where you indicate that delivery can be many months, or even
years, after executing a license agreement; and
•Explain when delivery and revenue recognition occur for your AFA
agreements, given your statement that there are two components to the contracts that
have license fees payable at different points in time.
10. Equity Investments, page F-34
11.We note that you use the equity method to account for your 10% interest in HOPU-ARM
Holding Company Limited. Please explain to us in detail, and revise the note to briefly
describe, how you exercise significant influence over this entity in accordance with ASC
323-10-15-6.
21. Segment and Geographic Information, page F-55
12.We note from page 40 the discussion of your pending litigation with your "major
customer," Qualcomm. Further, you disclose here that you have three customers that
collectively represented 42% of your revenue, including one customer that accounted for
18% of total revenue, for the year ended March 31, 2022. To enhance an investor's
understanding of your risk concentrations, please consider revising this note to name these
significant customers and to specifically disclose the percentage of your revenues that
Qualcomm represented in fiscal year ended March 31, 2022. Refer to ASC 275-10-50.
22. Subsequent Events, page F-55
13.Please tell us the nature of the "longstanding corporate governance issue" to which you
refer.
14.You describe on page 73 the corporate reorganization you intend to complete prior to the
completion of this offering. Also, on page F-56 you disclose that you will have Executive
Awards of $55 million that vest upon the occurrence of an IPO, and on page 140 that you
FirstName LastNameSpencer Collins
Comapany NameArm Holdings Limited
May 25, 2023 Page 4
FirstName LastName
Spencer Collins
Arm Holdings Limited
May 25, 2023
Page 4
granted a special cash award to your CEO that will vest upon completion of the offering.
In addition, disclosure on page 98 states that there will be share-based compensation
recognized upon completion of the offering. Please tell us what consideration you gave to
presenting pro forma financial information to reflect these material transactions, including
their impact on your equity and earnings per share amounts upon completion of the IPO.
Refer to SAB Topic 1.B.2 and Article 11 of Regulation S-X.
15.Please provide us your analysis of whether Arm Limited is a China-based issuer. Please
refer to the Division of Corporation Finance's Sample Letter to China-Based Companies
published on December 20, 2021.
You may contact Heather Clark at 202-551-3624 or Martin James at 202-551-3671 if you
have questions regarding comments on the financial statements and related matters. Please
contact Jenny O'Shanick at 202-551-8005 or Erin Purnell at 202-551-3454 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Manufacturing
cc: Justin Salon